WallStSmart

Bunge Limited (BG)vsDole PLC (DOLE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Bunge Limited generates 778% more annual revenue ($80.55B vs $9.17B). BG leads profitability with a 0.8% profit margin vs 0.6%. DOLE trades at a lower P/E of 15.0x. BG earns a higher WallStSmart Score of 59/100 (C).

BG

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 4.0Value: 6.7Quality: 4.5
Piotroski: 1/9

DOLE

Hold

44

out of 100

Grade: D

Growth: 4.0Profit: 5.0Value: 7.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.83
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BGUndervalued (+31.4%)

Margin of Safety

+31.4%

Fair Value

$177.95

Current Price

$130.37

$47.58 discount

UndervaluedFair: $177.95Overvalued
DOLEUndervalued (+80.9%)

Margin of Safety

+80.9%

Fair Value

$82.64

Current Price

$14.80

$67.84 discount

UndervaluedFair: $82.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BG2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
87.8%10/10

Revenue surging 87.8% year-over-year

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

DOLE2 strengths · Avg: 9.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

P/E RatioValuation
15.0x8/10

Attractively priced relative to earnings

Areas to Watch

BG4 concerns · Avg: 3.3/10
P/E RatioValuation
32.8x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.9%3/10

ROE of 4.9% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

DOLE4 concerns · Avg: 3.0/10
Market CapQuality
$1.44B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BG

The strongest argument for BG centers on Revenue Growth, Price/Book. Revenue growth of 87.8% demonstrates continued momentum. PEG of 1.37 suggests the stock is reasonably priced for its growth.

Bull Case : DOLE

The strongest argument for DOLE centers on Price/Book, P/E Ratio.

Bear Case : BG

The primary concerns for BG are P/E Ratio, Return on Equity, Profit Margin. Thin 0.8% margins leave little buffer for downturns.

Bear Case : DOLE

The primary concerns for DOLE are Market Cap, Profit Margin, Operating Margin. Thin 0.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

BG profiles as a hypergrowth stock while DOLE is a value play — different risk/reward profiles.

BG carries more volatility with a beta of 0.70 — expect wider price swings.

BG is growing revenue faster at 87.8% — sustainability is the question.

DOLE generates stronger free cash flow (67M), providing more financial flexibility.

Bottom Line

BG scores higher overall (59/100 vs 44/100) and 87.8% revenue growth. DOLE offers better value entry with a 80.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bunge Limited

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Bunge Limited is a global food and agribusiness company. The company is headquartered in St. Louis, Missouri.

Dole PLC

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Dole PLC is a preeminent global supplier of fresh produce, headquartered in Dublin, Ireland, and operating across more than 70 countries worldwide. With a strong focus on sustainability and innovation, Dole offers a comprehensive portfolio that includes bananas, pineapples, and packaged salads, addressing the increasing consumer demand for healthy food options. The company's efficient supply chain and strategically located distribution network enhance its ability to respond to market opportunities, positioning Dole as a key player in the agricultural sector and a robust growth prospect within the health and wellness market.

Visit Website →

Want to dig deeper into these stocks?